产品标题 产品货号 产品规格 厂家
Class II, major histocompatibility complex, transactivator (CIITA) from ORIGENE TECHNOLOGIESLY424845100 ugORIGENE TECHNOLOGIES
Clathrin, heavy chain-like 1 (CLTCL1), transcript variant 1 from ORIGENE TECHNOLOGIESLY416211100 ugORIGENE TECHNOLOGIES
Clathrin interactor 1 (CLINT1) from ORIGENE TECHNOLOGIESLY402360100 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5601895 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5610095 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5602745 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5610935 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5630345 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5622175 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5600655 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5608155 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5614045 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5603995 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5620515 ugORIGENE TECHNOLOGIES
Human RNA: Ovary-Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR566312n/aORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5630355 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenofibroma of ovary from ORIGENE TECHNOLOGIESCR5597845 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5606165 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCR5621435 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenofibroma of ovary from ORIGENE TECHNOLOGIESCR5629515 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, endometrioid, serous from ORIGENE TECHNOLOGIESCR5602445 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, endometrioid, papillary serous from ORIGENE TECHNOLOGIESCR5625635 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5594255 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, mucinous from ORIGENE TECHNOLOGIESCR5613025 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5602395 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5607245 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5601045 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5609925 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 16 (CCL16). from ORIGENE TECHNOLOGIESTP72326620 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 13 (CCL13). from ORIGENE TECHNOLOGIESTP72328620 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 17 (CCL17). from ORIGENE TECHNOLOGIESTP72343220 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 19 (CCL19). from ORIGENE TECHNOLOGIESTP72331520 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 21 (CCL21). from ORIGENE TECHNOLOGIESTP72308720 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 22 (CCL22). from ORIGENE TECHNOLOGIESTP72329120 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 2 (CCL2). from ORIGENE TECHNOLOGIESTP72328020 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 22 (CCL22). from ORIGENE TECHNOLOGIESTP72329220 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 24 (CCL24) from ORIGENE TECHNOLOGIESTP72108310 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 24 (CCL24). from ORIGENE TECHNOLOGIESTP72308120 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 26 (CCL26). from ORIGENE TECHNOLOGIESTP72308320 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 27 (CCL27). from ORIGENE TECHNOLOGIESTP72305820 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 28 (CCL28) from ORIGENE TECHNOLOGIESTP72060510 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 28 (CCL28). from ORIGENE TECHNOLOGIESTP72329420 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 3 (CCL3). from ORIGENE TECHNOLOGIESTP72330320 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 5 (CCL5). from ORIGENE TECHNOLOGIESTP72337320 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 7 (CCL7). from ORIGENE TECHNOLOGIESTP72328410 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 8 (CCL8) from ORIGENE TECHNOLOGIESTP72112010 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 8 (CCL8). from ORIGENE TECHNOLOGIESTP72328210 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 21 (CCL21 / 6CKine) from ORIGENE TECHNOLOGIESTP72379410 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 27 (CCL27 / CTACK) from ORIGENE TECHNOLOGIESTP72380810 ugORIGENE TECHNOLOGIES
Human chemokine (C-C motif) ligand 11 (CCL11 / Eotaxin) from ORIGENE TECHNOLOGIESTP72380210 ugORIGENE TECHNOLOGIES
 |< < 3070 3071 3072 3073 3074 3075 3076 3077 3078 > >| 第 3077/6274 页